Compare Edwards Lifesciences Corporation Common Stock (EW) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Vanguard Real Estate Index Fund ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Vanguard Real Estate Index Fund ETF trades at $90 (market cap $70.80B). The key difference: Vanguard Real Estate Index Fund ETF is the larger of the two by market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Vanguard Real Estate Index Fund ETF nearer its low. Which is the better fit depends on your goals.
| EW | VNQ | |
|---|---|---|
Market Cap | $49.44B | $70.80B |
Volume | 3,508,027 | 4,917,319 |
Sector | Health | — |
52-Week High | $95.18 | $100.95 |
52-Week Low | $72.65 | $87.00 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 112 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VNQ trades at $88.69, down 1.38% amid a bearish technical outlook with moving averages signaling sell pressure. The ETF faces headwinds from rising interest rates, which diminish its income appeal relative to Treasuries. Recent news highlights sector-wide selling pressure, though some contrarian investors see long-term value in oversold REITs. Key support sits at $88, with resistance at $89.
Outlook remains cautious due to interest rate sensitivity and competitive yield pressures. Opportunities exist for long-term investors seeking real estate exposure at discounted valuations, but near-term volatility from Fed policy and economic data poses risks. Monitor dividend sustainability and institutional flow trends for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
